Clinical outcome and immune reconstitution following alemtuzumab T cell depleted nonmyeloablative allogeneic immunotherapy from HLA matched siblings.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Rizzieri, DA; Koh, LP; Long, GD; Lagoo, AS; Gasparatto, C; Vredenburgh, JJ; Buckley, PJ; Gong, G; Loftis, J; Rowe, K; Rooney, B; Niedzweicki, D; Waters-Pick, B; Eren, P; Vujevich, D; Catlin, C; Folz, RJ; Sullivan, K; Horwitz, ME; Morris, A; Chao, NJ

Published Date

  • November 16, 2003

Published In

Volume / Issue

  • 102 / 11

Start / End Page

  • 238A - 239A

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 45th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • SAN DIEGO, CALIFORNIA

Conference End Date

  • December 9, 2003